COVID-19 New Cases 494... Over 400 for Three Consecutive Days

Foreign workers visiting the temporary screening clinic set up at Seoul Station Plaza on the 23rd are undergoing tests. Photo by Jinhyung Kang aymsdream@

[Asia Economy Reporter Lee Chun-hee] The cumulative number of COVID-19 cases in South Korea has remained in the 400s for three consecutive days.

The Korea Disease Control and Prevention Agency's Central Disease Control Headquarters (CDCH) announced on the 26th at midnight that the total number of confirmed COVID-19 cases increased by 494 from the previous day to 100,770.

The sources of infection for the new confirmed cases were 471 local transmissions and 23 imported cases.

About 70% of the locally transmitted cases occurred in the Seoul metropolitan area. There were 121 cases (25.7%) in Seoul, 187 cases (39.7%) in Gyeonggi, and 28 cases (5.9%) in Incheon, totaling 336 cases in the metropolitan area, accounting for 71.3% of all confirmed cases.

Among other regions, Gyeongnam Province, where cluster infections related to a bathhouse in Jinju City and entertainment establishments and companies in Geoje City continue to have an impact, reported the highest number of cases with 37. Other regions reported new confirmed cases as follows: 24 in Gangwon, 18 in Daegu, 13 in Daejeon, 12 in Gyeongbuk, 11 in Busan, 9 in Chungbuk, 3 in Jeonbuk, 2 each in Gwangju, Chungnam, Jeonnam, and Jeju. No new cases were reported in Ulsan and Sejong.

There were 23 imported cases. Among them, 3 were detected during quarantine, and 20 were confirmed in the community. Eight were Korean nationals and 15 were foreigners.

The number of patients who have recovered and been released from isolation reached 92,630, an increase of 562 from the previous day. Among the confirmed cases currently receiving hospital treatment, the number of critically ill patients remained at 111, unchanged from the previous day. The death toll rose by 7 to 1,716.

A total of 75,935 tests were conducted the previous day. At temporary screening clinics set up in the metropolitan area, 32,391 tests were performed, confirming 85 new cases.

Meanwhile, as of midnight on the same day, 32,466 people received new COVID-19 vaccinations, bringing the total number of first-dose recipients to 767,451. Among them, 707,481 received the AstraZeneca vaccine, and 59,970 received the Pfizer vaccine. With the start of the second dose of the Pfizer vaccine, an additional 1,142 people were vaccinated, bringing the total number of second-dose recipients to 3,833.

Reports of suspected adverse reactions increased by 103 cases, including one death, bringing the total to 10,113. Among the new reports, excluding the one death, 98 cases were mild symptoms such as headache, fever, nausea, and vomiting; 3 cases were suspected anaphylaxis; and 1 case was a suspected severe reaction such as convulsions.

This content was produced with the assistance of AI translation services.